Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming
1 Department of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
2 Department of Pharmacology and Experimental Therapeutics, Cardiovascular Center of Excellence, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA.
3 Stanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA.
4 Department of Interdisciplinary Oncology and Stanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA.
5 Proteomics Core facility, Louisiana State University Health Science Center (LSUHSC), New Orleans, LA, USA.
6 Department of Chemistry, Tulane University, New Orleans, LA, USA.
7 Department of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
8 Department of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA. [email protected].